Efficient methods for identifying mutated driver pathways in cancer

Bioinformatics

Volumn 28, Issue 22, 2012, Pages 2940-2947

  Zhao, Junfei ^a   Zhang, Shihua ^a   Wu, Ling Yun ^a   Zhang, Xiang Sun ^a  

^a CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN; METHODOLOGY; MUTATION; NEOPLASM; NUCLEOTIDE SEQUENCE;

ALGORITHMS; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASMS;

EID: 84869447682     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts564     Document Type: Article

References (32)

1. Akavia, U.D. et al. (2010) An integrated approach to uncover drivers of cancer. Cell, 143, 1005-1017.
2. Beretta, F. et al. (2009) The GluR2 subunit inhibits proliferation by inactivating Src-MAPK signalling and induces apoptosis by means of caspase 3/6-dependent activation in glioma cells. Eur. J. Neurosci., 30, 25-34.
3. Beroukhim, R. et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA, 104, 20007-20012.
4. Boca, S.M. (2010) Patient-oriented gene set analysis for cancer mutation data. Genome Biol., 11, R112.
5. Chapman, M.A. et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature, 471, 467-472.
6. Ciriello, G. et al. (2012) Mutual exclusivity analysis identifies oncogenic network modules. Genome Res., 22, 398-406.
7. David, L. et al. (2011) Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival. Cancer Res., 71, 4550-4561.
8. Ding, L. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
9. Efroni, S. (2011) Detecting cancer gene networks characterized by recurrent genomic alterations in a population. PLoS One, 6, e14437.
10. Fang, F. et al. (2009) Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am. J. Pathol., 174, 297-308.
11. Fidler, I.J. et al. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer, 3, 453-458. (Pubitemid 37328849)
12. Getz, G. et al. (2007) Comment on "The consensus coding sequences of human breast and colorectal cancers". Science, 317, 1500.
13. Goldberg, D.E. (1989) Genetic Algorithms in Search Optimization and Machine Learning. Addison Wesley, New Jersey.
14. Greenman, C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158. (Pubitemid 46398669)
15. Hahn, W.C. et al. (2002) Modelling the molecular circuitry of cancer. Nat. Rev. Cancer, 2, 331-341. (Pubitemid 37328946)
16. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70. (Pubitemid 30046295)
17. Ideker, T. et al. (2011) Boosting signal-to-noise in complex biology: prior knowledge is power. Cell, 144, 860-863.
18. Jones, S. et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
19. Miller, C.A. et al. (2011) Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. BMC Med. Genomics, 4, 34.
20. Overdevest, J.B. et al. (2009) Utilizing the molecular gateway: the path to personalized cancer management. Clin. Chem., 55, 684-697.
21. Qiu, Y.Q. et al. (2010) Detecting disease associated modules and prioritizing active genes based on high throughput data. BMC Bioinformatics, 11, 26.
22. Roel, G.W. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
23. Singer, S. et al. (2009) Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res., 69, 2234-2243.
24. Maas, S. et al. (2001) Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl Acad. Sci. USA, 98, 14687-14692. (Pubitemid 33121452)
25. Stransky, N. et al. (2011) The mutational landscape of head and neck squamous cell carcinoma. Science, 333, 1157-1160.
26. Swanton, C. et al. (2009) Molecular classification of solid tumours: towards pathway-driven therapeutics. Br. J. Cancer, 100, 1517-1522.
27. The Cancer Genome Atlas Research Network (TCGA) (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061-1068.
28. The Cancer Genome Atlas Research Network (TCGA) (2011) Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609-615.
29. Vandin, F. et al. (2012) De novo discovery of mutated driver pathways in cancer. Genome Res., 22, 375-385.
30. Vogelstein, B. et al. (2004) Cancer genes and the pathways they control. Nat. Med., 10, 789-799. (Pubitemid 39070849)
31. Yeang, C.H. et al. (2008) Combinatorial patterns of somatic gene mutations in cancer. FASEB J., 22, 2605-2622.
32. Zhang, S. et al. (2012) Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res., [Epub ahead of print, doi:10.1093/nar/gks725, August 8, 2012].